NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn ...

Novo Nordisk faces challenges but its pipeline remains strong. Find out why NVO stock could deliver high double-digit returns ...

NEW YORK, NY / ACCESS Newswire / February 7, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about ...

Novo Nordisk's CEO took a $1.5 million pay cut in 2024 as the pharma giant's share price tanked and it missed profit and DEI ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA ...

Moderna and Novo Nordisk are once again in the bad books ... earning it a suspension from the Association of the British Pharmaceutical Industry (ABPI) and a series of admonishments for ...

Novo Nordisk (NVO) has reportedly been criticized ... a self-regulatory body which administers the Association of the British Pharmaceutical Industry's Code of Practice, said in a report issued ...

Novo Nordisk shares rose sharply Friday after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial. Shares were 7 ...

Jelena Dokic has launched a staunch defence of Alex de Minaur and his performance against Jannik Sinner on Wednesday night after the Aussie was knocked out of the Australian Open in brutal fashion.